Omeprazole/sodium bicarbonate

DRUG5 trials

Sponsors

Bayer, Yvonne Romero, Food and Drug Administration (FDA)

Conditions

Erosive EsophagitisGastric AcidHealthy VolunteersHeartburnHuman Experimentation

Phase 1

A Study to Compare Omeprazole Administered as Zegerid® Powder and as Prilosec® Capsule in Healthy Participants (P08050)(CL2010-12)

CompletedNCT01337804

Start: 2011-01-31End: 2011-01-31Updated: 2015-02-23

Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets

CompletedNCT03100838

Food and Drug Administration (FDA)Healthy Volunteers

Start: 2017-03-20End: 2018-04-06Updated: 2019-08-16

Phase 3

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (CL2007-17 )(P07813)(COMPLETED)

CompletedNCT00674115

BayerGastric Acid, Human Experimentation

Start: 2008-04-30End: 2008-06-30Updated: 2015-03-11

A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(P07814)(COMPLETED)

CompletedNCT00765206

BayerGastric Acid, Human Experimentation

Start: 2008-05-31End: 2008-08-31Updated: 2015-03-11

Phase 4

Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study

CompletedNCT00693225

Yvonne RomeroErosive Esophagitis

Start: 2008-01-31End: 2010-12-31Updated: 2012-09-20